SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 60.86+11.2%Jan 22 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BulbaMan who wrote (5138)12/14/2001 12:06:46 PM
From: Cary Salsberg  Read Replies (3) of 52153
 
I just started reading this and the "Munch" thread the past few weeks. I am brand new to Biotech investing. In fact, I haven't done any. Since options are the subject, it seems, a priori, that Biotech could be a good area for way out of the money covered call writing. The future "potential" for a killing is always there, and that supports good call premiums. Do any of you have experience in Biotech covered call writing?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News